Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.04 |